PMID: 42539784

Pharmacologic targeting of midasin (MDN1) reveals a potential therapeutic vulnerability in ESR1-mutant breast cancer.

Pamukuntla Mounika, Ohemeng Afia, Banjara Bipika, Kotina Manasa, Pope Jillian L, Ali Simak, Darling-Reed Selina, Burow Matthew E, Gangapuram Madhavi, Eyunni Suresh

Frontiers in pharmacology · 2026

Vol. 17, pp. 1852788

This entry links to third-party literature. For research use only.